ReviewESMO open2025
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM).
Review in ESMO open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Sexual dysfunction outcomes and reporting disparities after multimodal treatment for rectal cancer: A systematic review and narrative synthesis.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026Pooled it
- Translation, cultural adaptation, and psychometric validation of the simplified Chinese EORTC QLQ-SH22 among cancer patients.Health and quality of life outcomes · 2026Article
- Sexuality in Adult Cancer Patients Living with Enterostomy or Urostomy: A Descriptive Phenomenological Study.Current oncology (Toronto, Ont.) · 2026Article
- Sexual Health Needs and Physician-Patient Interaction Experiences Among Postoperative Radical Prostatectomy Patients in China: A Qualitative Study.Nursing open · 2026Article
- Symptom Clusters and Symptom Burden in Cancer Survivors.Cancer medicine · 2026Article
- Sexual dysfunction after cancer: gender differences, tumor-specific patterns, and implications for sexual medicine practice.Oncology reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSexual dysfunction is often underestimated in cancer patients and survivors due to a lack of communication with health care providers and a common belief that it is an inevitable consequence of the disease and treatment. In recent years, with dramatically improved survival rates, increased attention has been paid to aspects of quality of life, particularly sexual health, which consists of physical, psychological, and emotional dimensions. A dedicated Associazione Italiana Oncologia Medica (AIOM) working group was built to provide an updated overview on this topic, including specific insights on prevalence, available therapies, and dedicated treatment paths. MATERIALS AND
methodsA narrative review was conducted to address the current understanding of sexual dysfunction in patients with cancer, treatment paradigms, and new available evidence.
conclusionsSexual health must be considered as a main item in global quality-of-life evaluation, with oncological treatments that can differently impact individuals with diverse sexual habits. Discussion with patients on their sexual life will allow clinicians to rapidly identify and therefore treat potential disease and treatment complications, promoting an improved doctor-patient relationship and overall well-being. If clinically indicated, the specific problem should be discussed with a dedicated consultant, to promote a multidisciplinary and tailored approach for every patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.